The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
Read More
Based on the results, in people with early symptomatic Alzheimer’s disease, Lilly says it plans to file for approval from the US Food and Drug Administration by the end of June.
Read More
Eli Lilly will expand in Research Triangle Park, adding additional manufacturing capacity for drug products. They’ll invest $450 million and hire 100 workers.
Read More
Labcorp announced this week a new testing program that provides genomic insights for cancer patients that is sponsored by Eli Lilly and Company.
Read More
As North Carolina experiences a biotechnology boom, a new community college center in Morrisville is putting those jobs within reach for more people.
Read More
We look inside Eli Lilly’s decision to select Concord for a new $1 billion manufacturing facility, its second in North Carolina in two years.
Read More
Eli Lilly will invest more than $1 billion and create nearly 600 jobs at a new manufacturing and operations facility in Concord.
Read More
Drug giant Eli Lilly, which is already building a new manufacturing facility in RTP, has acquired another 102 acres of land for a possible “future expansion possibility.”
Read More
Global pharmaceutical giant Eli Lilly and Company is interested in Durham-based Precision Biosciences’ genome editing technology and it’s putting its money where its interest is. Here’s a look at the mega deal between the two firms.
Read More
